EverSource Wealth Advisors’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$973	Buy	65 +41	+171%	+$614	﹤0.01%	3736
2025 Q1	$387	Buy	24 +16	+200%	+$258	﹤0.01%	3540
2024 Q4	$186	Buy	+8	New	+$186	﹤0.01%	3445